002755 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Beijing Aosaikang Pharmaceutical Co., Ltd. is engages in the research, development, production and sale of drugs. Its products include decitabine, fludarabine phosphate, nedaplatin, oxaliplatin, pemetrexed disodium, palonosetron hydrochloride, topotecan hydrochloride, zoledronic acid, temozolomide, tigencycline, lansoprazole, omeprazole, and parecoxib sodium. The company was founded on December 24, 1996 and is headquartered in Nanjing, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
002755 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company